Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $14.6050 (4.96%) ($13.8400 - $14.6400) on Fri. Sep. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.78% (three month average) | RSI | 47 | Latest Price | $14.6050(4.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD advances 2.6% a day on average for past five trading days. | Weekly Trend | FOLD declines -0.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(53%) IWO(50%) XBI(50%) IWM(47%) IWC(45%) | Factors Impacting FOLD price | FOLD will decline at least -1.39% in a week (0% probabilities). VIXM(-29%) VXX(-14%) UUP(-12%) UNG(-4%) IGOV(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.39% (StdDev 2.78%) | Hourly BBV | 2.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $14.04(4.02%) | 10 Day Moving Average | $13.76(6.14%) | 20 Day Moving Average | $14.03(4.1%) | To recent high | -8.1% | To recent low | 13.4% | Market Cap | $3.771b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |